Gamco Investors INC. ET AL Has $7.77 Million Stock Position in Stryker Co. (NYSE:SYK)

Gamco Investors INC. ET AL lifted its holdings in Stryker Co. (NYSE:SYK - Free Report) by 17.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,568 shares of the medical technology company's stock after acquiring an additional 3,150 shares during the quarter. Gamco Investors INC. ET AL's holdings in Stryker were worth $7,766,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of SYK. Norges Bank acquired a new stake in shares of Stryker in the fourth quarter valued at $1,710,744,000. Raymond James Financial Inc. acquired a new stake in Stryker in the 4th quarter valued at about $353,394,000. FMR LLC raised its stake in shares of Stryker by 10.0% in the fourth quarter. FMR LLC now owns 8,034,844 shares of the medical technology company's stock worth $2,892,946,000 after acquiring an additional 727,850 shares during the last quarter. Proficio Capital Partners LLC grew its stake in shares of Stryker by 52,520.8% during the fourth quarter. Proficio Capital Partners LLC now owns 596,194 shares of the medical technology company's stock valued at $214,660,000 after purchasing an additional 595,061 shares during the last quarter. Finally, APG Asset Management N.V. increased its holdings in shares of Stryker by 1,695.0% in the fourth quarter. APG Asset Management N.V. now owns 370,226 shares of the medical technology company's stock valued at $128,730,000 after purchasing an additional 349,601 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

Insider Activity at Stryker

In other news, Director Allan C. Golston sold 2,458 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the transaction, the director now directly owns 14,895 shares of the company's stock, valued at $5,705,827.65. This represents a 14.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ronda E. Stryker sold 201,392 shares of Stryker stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the sale, the director now directly owns 3,642,075 shares of the company's stock, valued at $1,428,567,498. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by company insiders.

Stryker Stock Up 1.8 %

Shares of SYK stock traded up $6.09 during trading on Tuesday, reaching $345.68. The company's stock had a trading volume of 309,521 shares, compared to its average volume of 1,587,034. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The business has a fifty day moving average price of $370.04 and a 200-day moving average price of $373.23. The company has a market cap of $131.94 billion, a price-to-earnings ratio of 44.55, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter last year, the firm earned $3.46 EPS. Analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.97%. Stryker's dividend payout ratio is presently 43.30%.

Analyst Ratings Changes

SYK has been the topic of a number of recent research reports. Needham & Company LLC reiterated a "buy" rating and issued a $442.00 price objective on shares of Stryker in a research report on Friday, March 21st. BTIG Research set a $403.00 price objective on Stryker and gave the stock a "buy" rating in a report on Monday, April 14th. Royal Bank of Canada increased their price objective on shares of Stryker from $425.00 to $435.00 and gave the company an "outperform" rating in a report on Wednesday, January 29th. StockNews.com lowered shares of Stryker from a "buy" rating to a "hold" rating in a report on Thursday, March 6th. Finally, Wells Fargo & Company raised their price target on Stryker from $427.00 to $435.00 and gave the stock an "overweight" rating in a research report on Wednesday, January 29th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Stryker currently has an average rating of "Moderate Buy" and a consensus price target of $423.53.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.